These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 34090951)
61. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus. Jones JO; Arvin AM Antiviral Res; 2005 Nov; 68(2):56-65. PubMed ID: 16118026 [TBL] [Abstract][Full Text] [Related]
62. Detection of varicella-zoster virus DNA by field-inversion gel electrophoresis. Arao Y; Yoshida M; Bai ZL; Kori Y; Nakatsukasa A; Takei Y; Aoji K; Yamada M; Uno F; Miyoshi K Microbiol Immunol; 1990; 34(3):269-82. PubMed ID: 2161996 [TBL] [Abstract][Full Text] [Related]
63. Manipulation of the Innate Immune Response by Varicella Zoster Virus. Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A Front Immunol; 2020; 11():1. PubMed ID: 32038653 [TBL] [Abstract][Full Text] [Related]
64. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults. Amlie-Lefond C; Gilden D J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380 [TBL] [Abstract][Full Text] [Related]
65. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236 [TBL] [Abstract][Full Text] [Related]
66. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections. Takayama M Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026 [TBL] [Abstract][Full Text] [Related]
67. Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons. Pomerantz HS; Xu X; White J; Sunil TS; Deiss RG; Ganesan A; Agan BK; Okulicz JF AIDS Res Ther; 2018 Dec; 15(1):25. PubMed ID: 30537970 [TBL] [Abstract][Full Text] [Related]
68. Persistence of varicella-zoster virus DNA in blood mononuclear cells of patients with varicella or zoster. Gilden DH; Devlin M; Wellish M; Mahalingham R; Huff C; Hayward A; Vafai A Virus Genes; 1989 Aug; 2(4):299-305. PubMed ID: 2554580 [TBL] [Abstract][Full Text] [Related]
69. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany. Sauerbrei A; Wutzler P J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537 [TBL] [Abstract][Full Text] [Related]
70. Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles. Storlie J; Carpenter JE; Jackson W; Grose C Virology; 2008 Dec; 382(2):171-81. PubMed ID: 18954885 [TBL] [Abstract][Full Text] [Related]
71. Absence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during herpes zoster: another immune evasion strategy? Nikkels AF; Sadzot-Delvaux C; Piérard GE Am J Dermatopathol; 2004 Feb; 26(1):27-32. PubMed ID: 14726820 [TBL] [Abstract][Full Text] [Related]
73. Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster. Park SY; Kim JY; Kwon JS; Jeon NY; Kim MC; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH J Med Virol; 2019 Nov; 91(11):1995-2000. PubMed ID: 31286531 [TBL] [Abstract][Full Text] [Related]
74. [Possibility of prevention of herpes zoster by use of varicella vaccine]. Kawano S; Terada K; Yagi Y; Kataoka N Kansenshogaku Zasshi; 1998 Jul; 72(7):714-9. PubMed ID: 9745221 [TBL] [Abstract][Full Text] [Related]
75. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. Dahl H; Marcoccia J; Linde A J Clin Microbiol; 1997 Feb; 35(2):347-9. PubMed ID: 9003593 [TBL] [Abstract][Full Text] [Related]
76. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4 Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406 [TBL] [Abstract][Full Text] [Related]
77. Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus. Carpenter JE; Henderson EP; Grose C J Virol; 2009 Jul; 83(13):6917-21. PubMed ID: 19369328 [TBL] [Abstract][Full Text] [Related]
78. A cell electrofusion microfluidic device integrated with 3D thin-film microelectrode arrays. Hu N; Yang J; Qian S; Joo SW; Zheng X Biomicrofluidics; 2011 Sep; 5(3):34121-3412112. PubMed ID: 22662046 [TBL] [Abstract][Full Text] [Related]
79. A Continuous Flow-through Microfluidic Device for Electrical Lysis of Cells. Lo YJ; Lei U Micromachines (Basel); 2019 Apr; 10(4):. PubMed ID: 31013954 [TBL] [Abstract][Full Text] [Related]
80. Assessment of virus infection in cultured cells using metabolic monitoring. Singhvi R; Markusen JF; Ky B; Horvath BJ; Aunins JG Cytotechnology; 1996 Jan; 22(1-3):79-85. PubMed ID: 22358917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]